Acumen Hypotension Prediction Index EV1000 Clinical Platform vs FFRangio System

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Acumen Hypotension Prediction Index EV1000 Clinical Platform

by Edwards Lifesciences

FFRangio System

by CathWorks (acquired by Medtronic)

AI Verdict

Tool A focuses on predicting and managing hypotensive events using continuous hemodynamic monitoring in acute care settings like critical care and surgery. Tool B, however, is designed to guide percutaneous coronary interventions by providing wire-free FFR measurements for coronary artery disease. While both leverage AI in cardiology and surgical contexts, their distinct clinical applications mean they address different patient needs and decision-making processes.

Choose Acumen Hypotension Prediction Index EV1000 Clinical Platform if…

Choose the Acumen Hypotension Prediction Index – EV1000 Clinical Platform if your primary goal is to proactively prevent and manage hypotensive events in real-time. This tool is ideal for anesthesiologists and critical care teams needing advanced warning of hemodynamic instability, allowing for timely interventions to optimize patient outcomes during surgery or in the ICU.

View Acumen Hypotension Prediction Index EV1000 Clinical Platform →

Choose FFRangio System if…

Choose the FFRangio System if you require a non-invasive, wire-free solution for assessing coronary artery disease and guiding percutaneous coronary intervention (PCI) decisions. This system is best suited for cardiologists seeking to quickly and accurately determine the functional significance of coronary lesions and optimize treatment strategies in the cath lab without the need for pressure wires or vasoactive drugs.

View FFRangio System →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Acumen Hypotension Prediction Index EV1000 Clinical Platform	FFRangio System
Pricing	Unknown	Contact vendor for pricing information.
Deployment	On-premise (integrated with EV1000 clinical platform and HemoSphere advanced monitoring platform)	SaaS, on-prem, hybrid
BAA Available	Unknown	Yes AI-estimated
FDA Status	Cleared AI-estimated	Cleared AI-estimated
HIPAA	Yes AI-estimated	Unknown

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Acumen Hypotension Prediction Index EV1000 Clinical Platform	FFRangio System
Name	Acumen Hypotension Prediction Index u0096 EV1000 Clinical Platform	FFRangio System
Company	Edwards Lifesciences	CathWorks
Tagline	Predicting and managing hypotension before it occurs.	A New Era in Coronary Physiology
Categories	Array	Array
Specialties	Array	Array
Key Features	Array	Array

Videos

Demos, reviews, and walkthroughs featuring Acumen Hypotension Prediction Index EV1000 Clinical Platform and FFRangio System.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How does each system integrate into existing clinical workflows and directly influence real-time clinical decision-making?

The Acumen HPI provides a likelihood score for hypotension up to 15 minutes in advance, along with Smart Alerts and insights into preload, afterload, and contractility, to guide proactive hemodynamic management in critical care and surgical settings. The FFRangio System offers real-time FFRangio values, a simulated pullback curve, and a Lesion Impact feature to help cardiologists quickly optimize and confirm PCI decisions for coronary artery disease patients, eliminating the need for invasive wires or drugs.

What is the depth of integration with the hospital's electronic health record (EHR) for data archiving and analysis beyond their primary platforms?

The Acumen HPI integrates with the Edwards Lifesciences HemoSphere Advanced Monitoring Platform, providing continuous hemodynamic monitoring data. While it can contribute to EHR data through systems like MPOG, the specific depth of direct, comprehensive integration for long-term archiving and analysis beyond its dedicated platform is not explicitly detailed. The FFRangio System seamlessly integrates with cath lab boom and PACS, which typically facilitates image and data archiving. The specific depth of integration with a hospital's overarching EHR system for comprehensive patient records is not further detailed in the provided information.

What clinical evidence or validation studies support the accuracy and reliability of each tool's predictions?

The Acumen HPI software has demonstrated high accuracy in predicting hypotension, with studies showing a positive predictive value of 98.3% and 99.9% in surgical patients, and at least 86.2% in non-surgical patients. An internal validation showed 89% specificity and 90% sensitivity at 10 minutes before an event, with an AUC of 0.95. The FFRangio System has demonstrated excellent diagnostic accuracy, with a pooled analysis of five prospective studies showing 93% diagnostic accuracy, 91% sensitivity, and 94% specificity when compared to invasive FFR. It has also shown comparable one-year major adverse cardiac event rates to invasive FFR in real-world registries and randomized controlled trials.

What is the expected learning curve for physicians and their support staff to achieve proficiency, and what training resources are provided?

For Acumen HPI, while a specific learning curve duration isn't stated, the system provides an HPI parameter, Smart Alerts, and various trend screens that require understanding for effective interpretation. Edwards Lifesciences offers clinical education resources including setup videos, quick reference guides, and product-specific training to support onboarding and daily workflows. For FFRangio, initial training enables quick attainment of maximal performance, with further practice primarily enhancing analysis speed while maintaining accuracy. The system is described as having an intuitive user interface and AI-aided analysis, and CathWorks provides support to help staff get comfortable with the technology.

What audit-trail functionalities are available in each system to track user interactions, system alerts, and subsequent clinical actions for quality assurance?

The Acumen HPI provides continuous hemodynamic monitoring and smart alerts, which generate data points for review, but specific audit-trail features for tracking user interactions or alert responses are not explicitly detailed in the provided information. Similarly, while the FFRangio System offers real-time FFRangio values and lesion assessment, generating data for post-procedure review, explicit audit-trail functionalities for user actions or decision support are not specified in the available facts.